Skip to main content
Journal cover image

Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials

Publication ,  Conference
van der Heijde, D; Weinblatt, M; Landewe, RB; Goel, N; Wells, AF; Fleischmann, RM
Published in: ARTHRITIS AND RHEUMATISM
September 1, 2008

Duke Scholars

Published In

ARTHRITIS AND RHEUMATISM

ISSN

0004-3591

Publication Date

September 1, 2008

Volume

58

Issue

9

Start / End Page

S529 / S530

Location

San Francisco, CA

Publisher

WILEY-LISS

Conference Name

72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals

Related Subject Headings

  • Arthritis & Rheumatology
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
van der Heijde, D., Weinblatt, M., Landewe, R. B., Goel, N., Wells, A. F., & Fleischmann, R. M. (2008). Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials. In ARTHRITIS AND RHEUMATISM (Vol. 58, pp. S529–S530). San Francisco, CA: WILEY-LISS.
Heijde, Desire van der, Michael Weinblatt, Robert B. Landewe, Niti Goel, Alvin F. Wells, and Roy M. Fleischmann. “Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials.” In ARTHRITIS AND RHEUMATISM, 58:S529–30. WILEY-LISS, 2008.
van der Heijde D, Weinblatt M, Landewe RB, Goel N, Wells AF, Fleischmann RM. Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials. In: ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2008. p. S529–30.
van der Heijde, Desire, et al. “Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials.” ARTHRITIS AND RHEUMATISM, vol. 58, no. 9, WILEY-LISS, 2008, pp. S529–30.
van der Heijde D, Weinblatt M, Landewe RB, Goel N, Wells AF, Fleischmann RM. Inhibition of progression of structural damage by week 16 with certolizumab pegol: Results from the RAPID trials. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2008. p. S529–S530.
Journal cover image

Published In

ARTHRITIS AND RHEUMATISM

ISSN

0004-3591

Publication Date

September 1, 2008

Volume

58

Issue

9

Start / End Page

S529 / S530

Location

San Francisco, CA

Publisher

WILEY-LISS

Conference Name

72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals

Related Subject Headings

  • Arthritis & Rheumatology
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences